Podjasek Jenna C, Jung Ji A, Kita Hirohito, Park Miguel A, Juhn Young J
Division of Allergic Diseases, Mayo Clinic , Rochester, MN , USA .
J Asthma. 2015 May;52(4):370-5. doi: 10.3109/02770903.2014.974815. Epub 2014 Oct 22.
There is no measure currently available to identify asthmatics with potential immune incompetence.
We propose use of a novel scoring system called the FACT score, which is formulated based on four parameters: (1) Family history of asthma, (2) Atopic conditions, (3) Bacterial colonization and (4) Th1 versus Th2 immune profile.
This was a cross-sectional study involving 16 asthmatics and 14 non-asthmatics. The first two parameters of the FACT score were obtained via a chart review and interview. For the third parameter, nasopharyngeal swab samples were cultured. The ratio of interleukin-5 to interferon-gamma for each patient was measured by peripheral blood mononuclear cells cultured with house dust mite. Antibodies to 23 pneumococcal antigens were used for humoral immunity.
The FACT scores for asthmatics (mean ± SD: 5.2 ± 1.87) were higher than those for non-asthmatics (mean ± SD: 3.3 ± 1.5) (p = 0.008). Of the 16 asthmatics, 7 (44%) had 12 or more positive serotype-specific polysaccharide antibodies, whereas 12 of 14 (86%) of non-asthmatics subjects had 12 or more positive serotype-specific polysaccharide antibodies (p = 0.014). Overall, the FACT score was inversely correlated with the number of positive serotype-specific antibody levels [rho (ρ) = -0.38, p = 0.04]. The proportions of subjects with 12 or more positive serotype-specific antibodies among non-asthmatics and asthmatics below and above the median of the FACT scores were 86, 50 and 38%, respectively (p = 0.052).
The FACT score may help us identify a subset of asthmatics with immune incompetence. Study findings need to be replicated in a larger study.
目前尚无可用的方法来识别具有潜在免疫功能不全的哮喘患者。
我们建议使用一种名为FACT评分的新型评分系统,该系统基于四个参数制定:(1)哮喘家族史,(2)特应性疾病,(3)细菌定植,以及(4)Th1与Th2免疫谱。
这是一项横断面研究,涉及16名哮喘患者和14名非哮喘患者。FACT评分的前两个参数通过病历审查和访谈获得。对于第三个参数,对鼻咽拭子样本进行培养。通过用屋尘螨培养外周血单核细胞来测量每位患者白细胞介素-5与干扰素-γ的比值。使用针对23种肺炎球菌抗原的抗体来评估体液免疫。
哮喘患者的FACT评分(均值±标准差:5.2±1.87)高于非哮喘患者(均值±标准差:3.3±1.5)(p = 0.008)。在16名哮喘患者中,7名(44%)具有12种或更多阳性血清型特异性多糖抗体,而14名非哮喘患者中有12名(86%)具有12种或更多阳性血清型特异性多糖抗体(p = 0.014)。总体而言,FACT评分与阳性血清型特异性抗体水平的数量呈负相关[rho(ρ)=-0.38,p = 0.04]。FACT评分中位数以下和以上的非哮喘患者和哮喘患者中,具有12种或更多阳性血清型特异性抗体的受试者比例分别为86%、50%和38%(p = 0.052)。
FACT评分可能有助于我们识别出一部分免疫功能不全的哮喘患者。研究结果需要在更大规模的研究中进行重复验证。